Neil Bell

Chief Development Officer at Avacta Life Sciences


Bell oversees pre-clinical and early clinical development of the company’s pre|CISION pro-drugs and Affimer immunotherapies

Bell has more than 30 years of expertise in drug development, with a number of senior roles in global pharmaceuticals and biotech companies. He most recently served as Senior Vice President, Head of Global Clinical Operations at cell and gene therapy company Autolus.


  • Chief Development Officer

    Current role

View in org chart